Definition:
The Cold and Cough market comprises over-the-counter natural and synthetic agents to relieve cough, expectorants and sore throat remedies, cold remedies and preparations against flu-like infections. Cough and cold medication includes medicines in the form of pills, syrups, lozenges, sprays, ointments and granulate for external and internal application. Not included are prescription medicines, preparations that are against the state law or are no explicit cold or cough drugs (e.g. painkillers). Among the top-selling medicines for cold and cough are nose sprays, Mucosolvan syrup, Grippostad C, Sinupret forte, Gelomyrtol, Dolo-Dobendan, Aspirin Complex, Bepanthen nose and eye cream, ACC Akut, Neo-Angin, Vick Vaporup, Isla Moos. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.
Additional Information:
The Cold and Cough market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.
Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.
Most recent update: Mar 2024
Source: Statista Market Insights
Most recent update: Mar 2024
Source: Statista Market Insights
Notes: The chart “Comparable Estimates” shows the forecasted development of the selected market from different sources. Please see the additional information for methodology and publication date.
Most recent update: Mar 2024
The Cold & Cough Remedies market in Botswana is experiencing steady growth due to various factors such as customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors.Customer preferences in Botswana play a significant role in the development of the Cold & Cough Remedies market. With the increasing awareness about health and wellness, customers are becoming more conscious of their well-being and are seeking remedies to alleviate cold and cough symptoms. Additionally, the preference for natural and herbal remedies is also on the rise, as customers are becoming more aware of the potential side effects of chemical-based medications. This shift in customer preferences towards natural remedies is driving the demand for herbal cold and cough remedies in the market.Trends in the market are also contributing to the development of the Cold & Cough Remedies market in Botswana. One major trend is the increasing availability and accessibility of over-the-counter cold and cough remedies. Pharmacies and retail stores are stocking a wide range of products to cater to the growing demand. This trend is not only making it easier for customers to purchase these remedies but also increasing competition among manufacturers, leading to product innovation and development.Local special circumstances in Botswana are also influencing the growth of the Cold & Cough Remedies market. The country has a high prevalence of respiratory infections, particularly during the winter season. This creates a constant demand for cold and cough remedies, as people seek relief from their symptoms. Additionally, the government and healthcare organizations in Botswana are actively promoting the importance of preventive measures and early treatment for respiratory infections, further driving the demand for cold and cough remedies.Underlying macroeconomic factors are also playing a role in the development of the Cold & Cough Remedies market in Botswana. The country's growing economy and increasing disposable income levels are enabling more people to afford these remedies. As a result, the market is witnessing an increase in the purchasing power of consumers, leading to higher sales and revenue for manufacturers and retailers.In conclusion, the Cold & Cough Remedies market in Botswana is developing due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. With the increasing awareness about health and wellness, the preference for natural remedies, and the availability of over-the-counter products, the market is expected to continue growing in the coming years.
Most recent update: Mar 2024
Source: Statista Market Insights
Most recent update: Mar 2024
Source: Statista Market Insights
Most recent update: Mar 2024
Source: Statista Market Insights
Data coverage:
Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.Modeling approach / Market size:
Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.Notes: Based on data from IMF, World Bank, UN and Eurostat
Most recent update: Sep 2024
Source: Statista Market Insights